Evidence map›Paper›PMID 35106126›Full record

ArticleNano research2022

Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity.

Ming Xia, Md Rejaul Hoq, Pengwei Huang, Wen Jiang, Xi Jiang, Ming Tan

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nano research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. EngineeringVaccines · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The αTSR Domain ofInternational journal of nanomedicine · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ming Xia *Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229 USA.
Md Rejaul Hoq *Department of Biological Sciences, Purdue Cryo-EM Facility, Purdue University, West Lafayette, IN 47907 USA.
Pengwei Huang *Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229 USA.
Wen JiangDepartment of Biological Sciences, Purdue Cryo-EM Facility, Purdue University, West Lafayette, IN 47907 USA.
Xi JiangDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229 USA.
Ming TanDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229 USA.
Cincinnati Children's Hospital Medical Center · USPurdue University West Lafayette · USUniversity of Cincinnati Medical Center · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
A Nanoparticle-Based Multivalent Rotavirus VaccineR56AI148426 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI TAN, MING · 2020 to 2020
$626k
NCATS NIH HHS UL1 TR001425NIAID NIH HHS R56 AI148426
6 · The paper itself

Abstract

Even with implementation of current influenza vaccines, influenza still claims up to 500,000 lives worldwide annually, indicating a need for a better vaccine strategy. We have developed a technology to generate unique S

Indexed as

hemagglutinininfluenza vaccineinfluenza virusnoroviruspseudovirus nanoparticleS60 nanoparticle

Identifiers

PMID35106126
PMCPMC8795936
OpenAlexW4210501440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.